Summary
- Main use
- Acute low back pain; relief of postoperative pain
- Who receives it
- Adults
- Adult administration
- 1. Postoperative pain Adults: Inject 50mg of dexketoprofen intramuscularly twice daily at 8~12-hour intervals, or administer by intravenous infusion 2~3 times daily at 6~8-hour intervals. For intravenous infusion, dilute 50mg of dexketoprofen in 100mL of 0.9% normal saline and infuse slowly over 30 minutes. The maximum allowable daily dose is 150mg. An opioid analgesic or acetaminophen may be coadministered to relieve severe postoperative pain. Do not use for a long period; administer only while symptoms are present. 2. Acute low back pain Adults: Inject 50mg of dexketoprofen intramuscularly twice daily. If pain is not relieved 30 minutes after administration of this drug, acetaminophen may be coadministered. Do not use for a long period; administer only while symptoms are present. Elderly patients: Dose adjustment is generally not necessary for elderly patients. However, renal function may be impaired in elderly patients; therefore, reduce the total daily dose to 50mg in patients with mild renal impairment. Patients with renal impairment: For patients with mild renal impairment (creatinine clearance 60~89ml/min), reduce the total daily dose to 50mg. This drug should not be administered to patients with moderate or severe renal impairment (creatinine clearance ≤ 59ml/min). Patients with hepatic impairment: For patients with mild or moderate hepatic impairment (Child-Pugh score 5-9), reduce the total daily dose to 50mg and closely monitor liver function. This drug should not be administered to patients with severe hepatic impairment (Child-Pugh score 10-15).
Ingredients
- Importer
- Menarini-Von Heyden GmbH
Efficacy & effects
Acute low back pain; relief of postoperative pain
- Postoperative pain
- acute low back pain
View approved original textHide original text
This medication is used to relieve pain that occurs after surgery and acute low back pain.
How it is given
Adult administration
1. Postoperative pain Adults: Inject 50mg of dexketoprofen intramuscularly twice daily at 8~12-hour intervals, or administer by intravenous infusion 2~3 times daily at 6~8-hour intervals. For intravenous infusion, dilute 50mg of dexketoprofen in 100mL of 0.9% normal saline and infuse slowly over 30 minutes. The maximum allowable daily dose is 150mg. An opioid analgesic or acetaminophen may be coadministered to relieve severe postoperative pain. Do not use for a long period; administer only while symptoms are present. 2. Acute low back pain Adults: Inject 50mg of dexketoprofen intramuscularly twice daily. If pain is not relieved 30 minutes after administration of this drug, acetaminophen may be coadministered. Do not use for a long period; administer only while symptoms are present. Elderly patients: Dose adjustment is generally not necessary for elderly patients. However, renal function may be impaired in elderly patients; therefore, reduce the total daily dose to 50mg in patients with mild renal impairment. Patients with renal impairment: For patients with mild renal impairment (creatinine clearance 60~89ml/min), reduce the total daily dose to 50mg. This drug should not be administered to patients with moderate or severe renal impairment (creatinine clearance ≤ 59ml/min). Patients with hepatic impairment: For patients with mild or moderate hepatic impairment (Child-Pugh score 5-9), reduce the total daily dose to 50mg and closely monitor liver function. This drug should not be administered to patients with severe hepatic impairment (Child-Pugh score 10-15).
Precautions
This medication may increase the risk of gastrointestinal bleeding in individuals who regularly consume more than three drinks of alcohol per day, so consultation with a physician or pharmacist is essential. This drug may affect the cardiovascular system and should be used cautiously in patients with cardiovascular diseases or risk factors, as abnormalities in blood pressure or heart function may occur, requiring careful monitoring for symptom onset. Gastrointestinal adverse effects such as bleeding, ulcers, and perforation may occur; therefore, elderly individuals or those with gastrointestinal diseases should be particularly cautious, and if abdominal pain or bleeding symptoms arise, immediate consultation with medical personnel is necessary. In the case of injectable ampoules, glass fragments may enter when cutting the container, so extreme caution is required while cutting, especially when administering to children or the elderly. This medication should not be administered to patients with specific allergic reactions, asthma, severe peptic ulcers, severe heart, kidney, or liver diseases, bleeding disorders, pregnant women, nursing mothers, children, and adolescents. Patients with esophagitis, gastritis, blood disorders, kidney or liver dysfunction, and the elderly should be monitored more closely when administered this medication, and drug interactions should also be taken into account. Various side effects affecting the nervous, digestive, circulatory, respiratory systems, blood, skin, etc., may occur infrequently; thus, any abnormal symptoms should be immediately reported to medical personnel. Women who are pregnant or nursing should not take this medication, and women who plan to become pregnant should also avoid its use. In case of overdose, gastrointestinal disturbances or neurological symptoms may occur, requiring immediate medical intervention. This medication should be diluted in a sterile environment and used as soon as possible after dilution; for storage, it should be kept away from direct sunlight and in a cool place. Safety and efficacy have not been established for children and adolescents; therefore, it should not be used in these populations, and elderly patients should start with a low dose and be closely monitored.
Side effects
Loss of consciousness, insomnia, fatigue, fever, sensory abnormalities, tinnitus, vomiting, abdominal pain, dyspepsia, obstruction, hematemesis, pancreatitis, hypotension, blood extravasation, bleeding, hyperlipidemia, ectopic beats, tachycardia, superficial transitional thrombophlebitis, peripheral edema, angioedema, facial edema, slow respiration, dyspnea, anemia, neutropenia, thrombocytopenia, hyperglycemia, hypoglycemia, ketonuria, proteinuria, menstrual disorders, prostate dysfunction, injection site pain, flushing, dry lips, dermatitis, injection site inflammation, urticaria, acne, severe cutaneous adverse reactions, photosensitivity, anaphylactoid reactions, jaundice, abnormal liver function test results, liver damage, sweating, muscle hypertonicity, muscle rigidity, muscle cramps, kidney pain, chills, pain, cold sensation, polyuria, aseptic meningitis, purpura, aplastic-hemolytic anemia, agranulocytosis, bone marrow failure, nausea, headache, dizziness, diarrhea, urinary disorders, dry mouth, myalgia, injection site pain
Not everyone experiences these, and they can vary from person to person.
Storage
This medication is sensitive to light; therefore, it should be stored in a light-protective container. Additionally, it is advisable to store the medication at room temperature between 1 to 30 degrees Celsius. Storing it this way helps maintain the medication's efficacy and safety.
Appearance and packaging
Appearance
This medication is an injection solution in a colorless, transparent liquid contained in a brown glass ampoule.
Package unit
2mL x 20 ampoules
Questions about this medicine
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.